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Vanoxonin, a new inhibitor of thymidylate synthetase, was found in cultured broths of the strain MG245-CF2 classified as Saccharopolyspora hirsuta. Vanoxonin, C15H25N3O9, was obtained as colorless powder. Vanoxonin forms a vanadium complex which exhibits a strong inhibition against thymidylate synthetase. The concentration for 50%. inhibition of the enzyme (IC50) was 0.7 ug/mi.
Thymidylate synthetase (EC 2.1.1.45) is an enzyme which catalyzes a reaction responsible for de nove TMP synthesis as follows:
5,10-methylenetetrahydrofolate+dUMP->dihydrofolate+TMP
The activity of this enzyme is usually elevated in tumor cells and regenerating liver compared with normal tissues1,2). Many synthetic antimetabolites inhibiting this enzyme such as 5-FU have been studied and used in cancer treatment'). Therefore, we searched for inhibitors of this enzyme in culture filtrates of microorganisms. In this screen, we used supernatants of 105,000 g centrifugation of Ehrlich carcinoma cell homogenate as the enzyme and added ATP to the reaction mixture, because we thought that some inhibitors might be converted to their active forms by phosphorylation as is known in the cases of showdomycin3) or 5-fluorodeoxyuridine3). An inhibitor thus found was shown that it was not activated by phosphorylation, but was activated by vanadium (V5+) which was a contaminate in ATP (sigma A6144)4). We named this inhibitor vanoxonin. The concentration for 50% inhibition of thymidylate synthetase was 200 ug/ml and that of vanoxonin-V5+ complex was 0.7 ug/ml.
In this paper, we report on the isolation and characterization of vanoxonin and the biological activities of its complex. The structure determination will be reported elsewhere.
Materials and Methods

Methods of Culture
The seed medium (pH 7) contained 1 % glucose, 1 % glycerol, 1 % sucrose, 0.5 % oat meal, 2 % soy bean meal, 1 % press yeast, 0.5 % Casamino Acids and 0.1 % CaCO3.
The production medium (pH 7.4) contained 1.5 % glycerol, 1.5 % cotton seed meal, 0.3 % NaCl and 0.5 % L-asparagine.
The vanoxonin-producing strain was classified as Saccharopolyspora hirsuta MG245-CF2 which was isolated from a soil collected at the compound of our Institute. A loopful amount of mycelium of its agar culture was inoculated to 100 ml of the seed medium in a 500-m1 Sakaguchi flask and shake-cultured for 4 days at 27°C. Fermentation was carried out in a 20-liter jar fermentor containing 12 liters of the production medium. After inoculation of 300 ml of the seed culture, the fermentation was continued at 27°C for 4 days with agitation (250 rpm) and aeration (12 liters/minute).
Enzymes
Thymidylate synthetase was prepared by the method of HEIDELBERGER1) modified as follows:
Ehrlich ascites carcinoma cells were harvested 7 days after intraperitoneal transplantation (1 x 106) to mice. The cells were washed 3 times with ice-cold isotonic saline and suspended in 2 volumes of cold 0.1 M phosphate buffer, pH 6.8. The cell suspension was disrupted for 2 minutes with Ultra-Turrax (Janke & Kunnkel KG. 1KA-Werk, TP18/2N) and centrifuged at 105,000g for 1 hour. The supernatant was used directly as the enzyme.
Assay for Inhibitory Activity Used for the Screening In order to obtain quantitative values for the anti-thymidylate synthetase activity, the method described by DUNLAP" was modified as follows: The reaction mixture for the assay was prepared by mixing 0.1 ml of 0.1 M phosphate buffer of pH 6.8, 0.05 ml of 20 mm ATP (Sigma A6144), 0.1 ml of 5.10-CH2H4 folate solution (which contains 0.1 mm dl, L-tetrahydrofolate, 1 mm formaldehyde, 25 mM NaHCO3, and 250 mm mercaptoethanol), 0.1 ml of 0.05 mm [5-3H]dUMP (5.6 µCi/umole), 0.1 ml distilled water with or without inhibitor, and 0.1 ml of an aqueous solution of thymidylate synthetase (total volume 0.5 ml) in a series of test tubes in a 37°C bath. After 30 minutes, the reaction was stopped by the addition of 0.1 ml of 1 N HCI. Acid-washed Norit A (40 mg) suspended in 0.5 ml of water was added and, after filtration through a Millipore membrane (0.45 uM) to remove the Norit which had adsorbed the unreacted [5-3H] dUMP, an 0.1 ml aliquot of the filtrate was added to 1 ml of scintillant (New England Nuclear, Aquasol-2) and the radioactivity was measured by an Aloka's scintillation counter LSC-653. The reaction was also carried out without the addition of the enzyme solution and the result was taken as blank. The concentration of the inhibitor required for 50%. inhibition (IC50) was calculated.
Assay for Activity of Vanoxonin to Inhibit Thymidylate Synthetase The same method used for the screening described in a previous paragraph was used, but ATP was omitted.
Animals Female CDF1 mice weighing 19-21 g and female ICR/S weighing 23'.25 g were used for the experiments.
Assay of Antitumor Activity Leukemia L-1210 cells were used for testing the cytotoxic activity of the vanoxonin-vanadium complex in vitro. The cells were suspended in Eagle MEM medium containing 10% fetal calf serum at a concentration of 1.0 x 108 cells/ml and cultivated at 37°C for 48 hours and the number of L-1210 cells was counted by a Coulter counter.
Ehrlich carcinoma and leukemia L-1210 were used for testing the antitumor activity of the complex in vivo: 1 x 105 L-1210 cells were inoculated intraperitoneally (i.p.) into CDF1 mice and the complex was intraperitoneally injected once daily for 10 days, starting on the day of tumor inoculation and the survival days were determined; 2 x 108 Ehrlich carcinoma cells were inoculated intraperitoneally into ICR/S mice. The vanadium complex was intraperitoneally injected once daily for 10 days, starting on the day of tumor inoculation, and the survival days were determined.
Results and Discussion
Isolation and Purification of Vanoxonin
The maximal production of vanoxonin was attained after 4 days as shown in Fig. 1 . A culture filtrate (30 liters) was adjusted to pH 2.0 and passed through a column of Diaion HP-20 (10.5 x 100 cm). The column was washed with distilled water and the vanoxonin was eluted with 10 liters of 20 % aqueous acetone. The eluate was concentrated under reduced pressure to a syrup and dissolved in 3 liters of water. After the pH was adjusted to 2.0, vanoxonin was extracted with 9 liters of 1-butanol. The extract was concentrated under reduced pressure to a syrup and dissolved in 1.5 liter of water. After the pH was adjusted to 7.0, the solution was applied to a DEAE Sephadex A-25 column (2.2 x 53 cm).
The active fraction was eluted with a linear gradient from water to 1 M NaCl (each 1 liter) and desalted The structure determination will be reported elsewhere.
Effect of Metal Ions on the Activity of Vanoxonin in
Inhibiting Thymidylate Synthetase
The activity of vanoxonin in inhibiting thymidylate synthetase was tested in the reaction mixture with varying amounts of vanadium and other metals. As shown in Table 1 , vanadium was found to be a specific activator of vanoxonin. It was assumed that three molecules of vanoxonin combined to a vanadate ion to form a green complex and the complex showed inhibitory activity against thymidylate synthetase. Detailed structural studies of the complex will be reported elsewhere. Table 1 . Effect of metals on the inhibitory activity of vanoxonin (inhibition %).
Metals
Bat} ( Reaction conditions were the same as described in Materials and Methods except that 5µg/ml of vanoxonin and various concentrations of metals were added and ATP was omitted. Reaction condition was the same as described in Materials and Methods except that various concentrations of the inhibitor were added. 
Biological Activities of Vanoxonin-vanadium Complex
The complex inhibited thymidylate synthetase as shown in Fig. 4 . The concentration of the complex required for 50 % inhibition (IC,,) was 0.7 ug/ml.
The in vitro cytotoxic activity of the complex was examined against L-1210 lymphatic leukemia Concentration of the inhibitor (v9/ml; cells, and the minimum inhibitory concentration of the complex was 25 ,ug/ml. Intraperitoneal administration of the complex exhibited a weak antitumor activity against L-1210 mouse leukemia and Ehrlich ascites carcinoma as shown in Table 2 , although vanoxonin itself showed no activity in prolonging the survival period. Vanoxonin and its vanadium complex did not show any antimicrobial activity and the LD50 value of the complex in mice was 100 mg/kg by intravenous injection, but vanoxonin had a low toxicity; no deaths occurred after its intravenous injection of 100 mg/kg to mice.
